Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective

M Ravera, E Bussalino, M Fusaro, L Di Lullo… - Journal of …, 2020 - Springer
Atrial fibrillation (AF) is highly prevalent among patients with chronic kidney disease (CKD),
and also associated with unfavorable outcome. Anticoagulant therapy is the mainstep of …
被引用次数：26 相关文章

Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective

M Ravera, E Bussalino, M Fusaro… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Atrial fibrillation (AF) is highly prevalent among patients with chronic kidney disease (CKD),
and also associated with unfavorable outcome. Anticoagulant therapy is the mainstep of …

[引用][C] Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective

M Ravera, E Bussalino, M Fusaro, L Di Lullo… - Journal of …, 2020 - cir.nii.ac.jp
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney
disease: the nephrologist’s perspective | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective

M Ravera, E Bussalino, M Fusaro, L Di Lullo… - Journal of …, 2020 - hero.epa.gov
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney
disease: the nephrologist's perspective | Health & Environmental Research Online (HERO) …

Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.

M Ravera, E Bussalino, M Fusaro, L Di Lullo… - Journal of …, 2020 - europepmc.org
Atrial fibrillation (AF) is highly prevalent among patients with chronic kidney disease (CKD),
and also associated with unfavorable outcome. Anticoagulant therapy is the mainstep of …